Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Alias:
Combined Hepatocellular-Cholangiocarcinoma
Hepatocholangiocarcinoma
Hepatocellular Carcinoma with Cholangiocarcinoma
Mixed Hepatocellular and Bile Duct Carcinoma
Combined Hcc-Cc
Chcc-Cc
Favorite
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Combined Hepatocellular Carcinoma and Cholangiocarcinoma, also known as combined hepatocellular-cholangiocarcinoma, is related to cholangiocarcinoma and hepatocellular carcinoma. The drugs Atezolizumab and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include liver and endothelial.
Related ID:
ICD11:1097637010

Basic Information

Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
--
Adult
--
--
--
--

Medical Symptom

#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available

Gene & Mutation

#
Gene
Function
Score
Mutations
No data available

Related Drugs

Name
CAS Number
Status
Phase
No data available

Disease Model

Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top